uniQure N.V. (QURE) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Unicure first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To answer your question, press star 11 again. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker for today, Chiara Russo, Senior Director of Investor Relations. Please go ahead. Thank you. Good morning, and thank you for joining us for Unicare's inaugural quarterly earnings call. Earlier this morning, Unicare released its financial results for the first quarter of 2025. The press release is available on the Investors in Media section of our website at unicure.com, and our 10Q will be filed with the SEC later today. Joining me on the call this morning are Matt Capusa, Chief Executive Officer, Dr. Walid Abisab, Chief Medical Officer, and Christian Klemp, our Chief Financial Officer. After our formal remarks, we'll open up the call for Q&A. Please know that we'll be making forward-looking statements during this investor call. All statements, other than statements of historical fact, are forward-looking statements. They are based on management's beliefs and assumptions, and on information available to management only as of the date of this conference call. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitations, the factors described in UNICUR's most recent SEC filings. Given these risks, you should not put undue re...